Skip to main content
Erschienen in: European Radiology 1/2024

11.08.2023 | Magnetic Resonance

MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis

verfasst von: Stephan Altmayer, Larissa Maria Armelin, Jussara Soares Pereira, Lis Vitoria Carvalho, Justin Tse, Patricia Balthazar, Martina Zaguini Francisco, Guilherme Watte, Bruno Hochhegger

Erschienen in: European Radiology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

To perform a systematic review and meta-analysis to evaluate if magnetic resonance imaging (MRI) with diffusion weighted imaging (DWI) adds value compared to contrast-enhanced computed tomography (CECT) alone in the preoperative evaluation of pancreatic cancer.

Methods

MEDLINE, EMBASE, and Cochrane databases were searched for relevant published studies through October 2022. Studies met eligibility criteria if they evaluated the per-patient diagnostic performance of MRI with DWI in the preoperative evaluation of newly diagnosed pancreatic cancer compared to CECT. Our primary outcome was the number needed to treat (NNT) to prevent one futile surgery using MRI with DWI, defined as those in which CECT was negative and MRI with DWI was positive for liver metastasis (i.e., surgical intervention in metastatic disease missed by CECT). The secondary outcomes were to determine the diagnostic performance and the NNT of MRI with DWI to change management in pancreatic cancer.

Results

Nine studies met the inclusion criteria with a total of 1121 patients, of whom 172 had liver metastasis (15.3%). The proportion of futile surgeries reduced by MRI with DWI was 6.0% (95% CI, 3.0–11.6%), yielding an NNT of 16.6. The proportion of cases that MRI with DWI changed management was 18.1% (95% CI, 9.9–30.7), corresponding to an NNT of 5.5. The per-patient sensitivity and specificity of MRI were 92.4% (95% CI, 87.4–95.6%) and 97.3% (95% CI, 96.0–98.1).

Conclusion

MRI with DWI may prevent futile surgeries in pancreatic cancer by improving the detection of occult liver metastasis on preoperative CECT with an NNT of 16.6.

Clinical relevance statement

MRI with DWI complements the standard preoperative CECT evaluation for liver metastasis in pancreatic cancer, improving the selection of surgical candidates and preventing unnecessary surgeries.

Key Points

• The NNT of MRI with DWI to prevent potential futile surgeries due to occult liver metastasis on CECT, defined as those in which CECT was negative and MRI with DWI was positive for liver metastasis, in patients with pancreatic cancer was 16.6.
• The higher performance of MRI with DWI to detect liver metastasis occult on CECT can be attributed to an increased detection of subcentimeter liver metastasis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
3.
Zurück zum Zitat Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388:73–85CrossRef Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet 388:73–85CrossRef
4.
Zurück zum Zitat Allen VB, Gurusamy KS, Takwoingi Y, et al (2016) Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 7:CD009323 Allen VB, Gurusamy KS, Takwoingi Y, et al (2016) Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev 7:CD009323
5.
6.
Zurück zum Zitat Tempero MA, Malafa MP, Al-Hawary M, et al (2022) Pancreatic adenocarcinoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(4):439–457 Tempero MA, Malafa MP, Al-Hawary M, et al (2022) Pancreatic adenocarcinoma, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(4):439–457
7.
Zurück zum Zitat Ducreux M, Cuhna AS, Caramella C et al (2015) Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:v56–v68CrossRefPubMed Ducreux M, Cuhna AS, Caramella C et al (2015) Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:v56–v68CrossRefPubMed
8.
Zurück zum Zitat Somers I, Bipat S (2017) Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT. Eur Radiol 27:3408–3435CrossRefPubMedPubMedCentral Somers I, Bipat S (2017) Contrast-enhanced CT in determining resectability in patients with pancreatic carcinoma: a meta-analysis of the positive predictive values of CT. Eur Radiol 27:3408–3435CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Yamaguchi T, Sofue K, Ueshima E et al (2022) Abbreviated gadoxetic acid-enhanced MRI for the detection of liver metastases in patients with potentially resectable pancreatic ductal adenocarcinoma. J Magn Reson Imaging 56:725–736 Yamaguchi T, Sofue K, Ueshima E et al (2022) Abbreviated gadoxetic acid-enhanced MRI for the detection of liver metastases in patients with potentially resectable pancreatic ductal adenocarcinoma. J Magn Reson Imaging 56:725–736
10.
Zurück zum Zitat Riviere DM, van Geenen EJM, van der Kolk BM et al (2019) Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. Abdom Radiol (NY) 44:1756–1765CrossRefPubMed Riviere DM, van Geenen EJM, van der Kolk BM et al (2019) Improving preoperative detection of synchronous liver metastases in pancreatic cancer with combined contrast-enhanced and diffusion-weighted MRI. Abdom Radiol (NY) 44:1756–1765CrossRefPubMed
11.
Zurück zum Zitat Marion-Audibert AM, Vullierme MP, Ronot M et al (2018) Routine MRI with DWI sequences to detect liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: a prospective multicenter study. AJR Am J Roentgenol 211:W217–W225CrossRefPubMed Marion-Audibert AM, Vullierme MP, Ronot M et al (2018) Routine MRI with DWI sequences to detect liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: a prospective multicenter study. AJR Am J Roentgenol 211:W217–W225CrossRefPubMed
12.
Zurück zum Zitat Jeon SK, Lee JM, Joo I et al (2018) Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Eur Radiol 28:3484–3493CrossRefPubMed Jeon SK, Lee JM, Joo I et al (2018) Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. Eur Radiol 28:3484–3493CrossRefPubMed
13.
Zurück zum Zitat Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed
14.
Zurück zum Zitat Ishikawa T, Ohno E, Mizutani Y et al (2022) Comparison of contrast-enhanced transabdominal ultrasonography following endoscopic ultrasonography with GD-EOB-DTPA-enhanced MRI for the sequential diagnosis of liver metastasis in patients with pancreatic cancer. J Hepatobiliary Pancreat Sci 29:682–692CrossRefPubMed Ishikawa T, Ohno E, Mizutani Y et al (2022) Comparison of contrast-enhanced transabdominal ultrasonography following endoscopic ultrasonography with GD-EOB-DTPA-enhanced MRI for the sequential diagnosis of liver metastasis in patients with pancreatic cancer. J Hepatobiliary Pancreat Sci 29:682–692CrossRefPubMed
15.
Zurück zum Zitat Holzapfel K, Reiser-Erkan C, Fingerle AA et al (2011) Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging 36:179–184CrossRefPubMed Holzapfel K, Reiser-Erkan C, Fingerle AA et al (2011) Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging 36:179–184CrossRefPubMed
16.
Zurück zum Zitat Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed
17.
Zurück zum Zitat Chew C, O’Dwyer P (2015) The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography. Singapore Med J 57:334–338CrossRef Chew C, O’Dwyer P (2015) The value of liver magnetic resonance imaging in patients with findings of resectable pancreatic cancer on computed tomography. Singapore Med J 57:334–338CrossRef
18.
Zurück zum Zitat Raman SP, Reddy S, Weiss MJ et al (2015) Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. Am J Roentgenol 204:W37–W42CrossRef Raman SP, Reddy S, Weiss MJ et al (2015) Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. Am J Roentgenol 204:W37–W42CrossRef
19.
Zurück zum Zitat Glant JA, Waters JA, House MG et al (2011) Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma? Surgery 150:607–616CrossRefPubMed Glant JA, Waters JA, House MG et al (2011) Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma? Surgery 150:607–616CrossRefPubMed
20.
Zurück zum Zitat Van den Broeck A, Sergeant G, Ectors N et al (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604CrossRefPubMed Van den Broeck A, Sergeant G, Ectors N et al (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604CrossRefPubMed
21.
Zurück zum Zitat Hong SB, Choi SH, Kim KW et al (2020) Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. J Magn Reson Imaging 51:1737–1744CrossRefPubMed Hong SB, Choi SH, Kim KW et al (2020) Meta-analysis of MRI for the diagnosis of liver metastasis in patients with pancreatic adenocarcinoma. J Magn Reson Imaging 51:1737–1744CrossRefPubMed
22.
Zurück zum Zitat Alabousi M, McInnes MD, Salameh J et al (2021) MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: a comparative diagnostic test accuracy systematic review and meta-analysis. J Magn Reson Imaging 53:38–48CrossRefPubMed Alabousi M, McInnes MD, Salameh J et al (2021) MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: a comparative diagnostic test accuracy systematic review and meta-analysis. J Magn Reson Imaging 53:38–48CrossRefPubMed
23.
Zurück zum Zitat Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700–b2700CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700–b2700CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Whiting PF (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529CrossRefPubMed Whiting PF (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529CrossRefPubMed
25.
Zurück zum Zitat Gassert FG, Ziegelmayer S, Luitjens J et al (2022) Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis. Eur Radiol 32:2448–2456CrossRefPubMed Gassert FG, Ziegelmayer S, Luitjens J et al (2022) Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis. Eur Radiol 32:2448–2456CrossRefPubMed
26.
Zurück zum Zitat Kachare SD, Liner KR, Vohra NA et al (2015) Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre. HPB (Oxford) 17:311–317CrossRefPubMed Kachare SD, Liner KR, Vohra NA et al (2015) Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre. HPB (Oxford) 17:311–317CrossRefPubMed
27.
Zurück zum Zitat Go DE, Abbott DE, Wima K et al (2016) Addressing the high costs of pancreaticoduodenectomy at safety-net hospitals. JAMA Surg 151:908CrossRefPubMed Go DE, Abbott DE, Wima K et al (2016) Addressing the high costs of pancreaticoduodenectomy at safety-net hospitals. JAMA Surg 151:908CrossRefPubMed
28.
Zurück zum Zitat Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted Imaging. Radiology 246:812–822CrossRefPubMed Parikh T, Drew SJ, Lee VS et al (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted Imaging. Radiology 246:812–822CrossRefPubMed
29.
Zurück zum Zitat Wu LM, Hu J, Gu HY et al (2013) Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Eur J Cancer 49:572–584CrossRefPubMed Wu LM, Hu J, Gu HY et al (2013) Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Eur J Cancer 49:572–584CrossRefPubMed
30.
Zurück zum Zitat Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver mr imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid–enhanced MR imaging, and a combination of both MR techniques. Radiology 274:712–722CrossRefPubMed Kim HJ, Lee SS, Byun JH et al (2015) Incremental value of liver mr imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid–enhanced MR imaging, and a combination of both MR techniques. Radiology 274:712–722CrossRefPubMed
31.
Zurück zum Zitat Litjens G, Rivière DM, van Geenen EJM et al (2020) Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: study protocol for an international, multicenter, diagnostic trial. BMC Cancer 20:744CrossRefPubMedPubMedCentral Litjens G, Rivière DM, van Geenen EJM et al (2020) Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: study protocol for an international, multicenter, diagnostic trial. BMC Cancer 20:744CrossRefPubMedPubMedCentral
Metadaten
Titel
MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer: a systematic review and meta-analysis
verfasst von
Stephan Altmayer
Larissa Maria Armelin
Jussara Soares Pereira
Lis Vitoria Carvalho
Justin Tse
Patricia Balthazar
Martina Zaguini Francisco
Guilherme Watte
Bruno Hochhegger
Publikationsdatum
11.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 1/2024
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-023-10069-5

Weitere Artikel der Ausgabe 1/2024

European Radiology 1/2024 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.